Emerald Therapeutics, Inc. — Form D
Emerald Therapeutics, Inc. of MENLO PARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2014-02-21. The offering totals $6.0M, of which $5.6M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2014-02-21
- Form: D
- Accession: 0001501852-14-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $5.6M
- Remaining: $390K
- Investors: 5
- Date of first sale: 2014-02-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-212307
Issuer
- Name: Emerald Therapeutics, Inc.
- CIK: 0001501852
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 3745-M EDISON WAY, MENLO PARK, CA, 94025
- Phone: 650-257-7554
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Brian J Frezza | Director | Menlo Park, CA |
| Daniel J Kleinbaum | Director | Menlo Park, CA |
| Max R Levchin | Director | San Francisco, CA |
| Brian R Singerman | Director | Menlo Park, CA |
| Brian J Frezza | Executive Officer | Menlo Park, CA |
| Daniel J Kleinbaum | Executive Officer | Menlo Park, CA |
| Brian Frezza | Director | Menlo Park, CA |
| Brian Frezza | Executive Officer | Menlo Park, CA |
| Luke R Nosek | Director | Menlo Park, CA |
| Luke J Nosek | Director | San Francisco, CA |
Other filings by this issuer (3)
More